Navigating the Intersection of AI and Biology: A Vision for Drug Discovery| Sean McClain, CEO, Absci Corp. 00:10:00
In this conversation, the CEO of the Future of Today Institute discusses the innovative approach to drug discovery with Sean McClain, highlighting the fusion of AI and biology at Absci. They delve into Absci's groundbreaking work, explaining complex concepts in a simplified manner, while also addressing the importance of collaboration between tech and biotech industries. The discussion extends to Absci's partnership with NVIDIA and the potential impact on healthcare, emphasizing the need for a long-term perspective amidst the evolving landscape of AI-driven drug development.
